A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Clinical trial NCT07717411 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07717411
- Sponsor
- Hoffmann-La Roche
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-30
- Primary completion
- 2032-09-03
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.